Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $512,419 - $600,361
-2,414 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $33,869 - $37,575
-145 Reduced 5.67%
2,414 $588,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $55,699 - $64,908
-251 Reduced 8.93%
2,559 $637,000
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $97,154 - $115,693
-449 Reduced 13.78%
2,810 $646,000
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $95,267 - $105,945
406 Added 14.23%
3,259 $828,000
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $564,351 - $692,537
2,853 New
2,853 $673,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $367,395 - $487,267
-2,016 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $381,447 - $490,291
2,016 New
2,016 $486,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.